UroGen Pharma (URGN) EBIT Growth (3y) (2020 - 2026)
UroGen Pharma (URGN) EBIT Growth (3y) (2020 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | - |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 38.78% |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 13.47% |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | -12.10% |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | 79.65% |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | - |
| 10 | UroGen Pharma | 2.05 Bn | 1.91 Bn | 46.82 Mn | 2.77% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 2.77% |
| Dec 31, 2025 | 1.96% |
| Sep 30, 2025 | -14.83% |
| Jun 30, 2025 | -30.35% |
| Mar 31, 2025 | -18.91% |
| Dec 31, 2024 | -11.57% |
| Sep 30, 2024 | 9.20% |
| Jun 30, 2024 | -4.22% |
| Mar 31, 2024 | 0.48% |
| Dec 31, 2023 | 18.77% |
| Sep 30, 2023 | 22.61% |
| Jun 30, 2023 | 21.50% |
| Mar 31, 2023 | 17.00% |
| Dec 31, 2022 | 20.15% |
| Sep 30, 2022 | 8.30% |
| Jun 30, 2022 | 7.64% |
| Mar 31, 2022 | 0.71% |
| Dec 31, 2021 | 6.05% |
| Sep 30, 2021 | -3.59% |
| Jun 30, 2021 | -7.38% |